Works matching IS 02533766 AND DT 2024 AND VI 46 AND IP 7

Results: 10

2022 年全球恶性肿瘤统计报告解读.

Published in:

Chinese Journal of Oncology, 2024, v. 46, n. 7, p. 710, doi. 10.3760/cma.j.cn112152-20240416-00152

By:

张希;
杨雷;
刘硕;
曹莉莉;
王宁;
李慧超;
季加孚

Publication type:

Article

尿液细胞学巴黎报告系统在肿瘤专科医院临床应用的真实世界研究.

Published in:

Chinese Journal of Oncology, 2024, v. 46, n. 7, p. 703, doi. 10.3760/cma.j.cn112152-20230731-00049

By:

赵焕;
张智慧;
郭会芹;
韦娜;
马海玥;
赵琳琳;
孙悦;
王聪;
常馨香;
毕新刚;
邢念增

Publication type:

Article

安罗替尼联合尼拉帕利治疗铂耐药复发性卵巢癌的疗效及安全性分析.

Published in:

Chinese Journal of Oncology, 2024, v. 46, n. 7, p. 696, doi. 10.3760/cma.j.cn112152-20231024-00224

By:

杨萌;
王晶晶;
邓少琼;
梁思思;
孙力

Publication type:

Article

血清甲胎蛋白升高伴肠母细胞分化胃腺癌的分子特征分析.

Published in:

Chinese Journal of Oncology, 2024, v. 46, n. 7, p. 686, doi. 10.3760/cma.j.cn112152-20230710-00004

By:

昝丽坤;
申璐璐;
张鑫;
高宁;
田宝国;
耿小鑫;
彭潇;
李佳芠;
步鹏;
赵国海

Publication type:

Article

circ_0000263 通过 miR-338-3p/TERT 抑制端粒酶蛋白活性影响 HeLa 细胞生物学功能提高放射敏感性.

Published in:

Chinese Journal of Oncology, 2024, v. 46, n. 7, p. 676, doi. 10.3760/cma.j.cn112152-20231024-00244

By:

王冲;
霍研锟;
李梦亚;
李潺;
申晓辉;
王树娟;
刘延方;
姜中兴

Publication type:

Article

circ_BACH2 通过调控 miR-370-3p 影响甲状腺乳头状癌的恶性生物学行为.

Published in:

Chinese Journal of Oncology, 2024, v. 46, n. 7, p. 663, doi. 10.3760/cma.j.cn112152-20231024-00245

By:

孙璞;
冯勇;
周连仲;
裴斐;
苏玢;
乔晓丞

Publication type:

Article

中国食管癌时空分布特征研究.

Published in:

Chinese Journal of Oncology, 2024, v. 46, n. 7, p. 657, doi. 10.3760/cma.j.cn112152-20230726-00040

By:

赖少萍;
粟海媚;
刘亚文;
张孟齐;
黄振秋;
刘佳欣;
黄宏

Publication type:

Article

中美两国恶性肿瘤疾病负担、流行趋势及归因风险因素比较.

Published in:

Chinese Journal of Oncology, 2024, v. 46, n. 7, p. 646, doi. 10.3760/cma.j.cn112152-20240208-00068

By:

吉雨婷;
刘斯文;
张芸萌;
段洪媛;
刘晓敏;
冯卓伟;
李净净;
吕章艳;
黄育北

Publication type:

Article

骨改良药物用于恶性肿瘤骨转移治疗的安全性共识（2024 版）.

Published in:: Chinese Journal of Oncology, 2024, v. 46, n. 7, p. 637, doi. 10.3760/cma.j.cn112152-20240111-00022
Publication type:: Article

Ⅳ 期原发性肺癌中国治疗指南（2024 版）.

Published in:: Chinese Journal of Oncology, 2024, v. 46, n. 7, p. 595, doi. 10.3760/cma.j.cn112152-20240311-00104
Publication type:: Article